相关实验视频

Updated: Jul 17, 2025

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction

Published on: April 5, 2018

目前的格局和RET和ROS1目标的未来前景

Hai-Long Zhang¹, Qian Kong²

¹Central International Intellectual Property (Baotou) Co., Ltd., Baotou, 014030, China.

Pharmaceutical patent analyst

|September 6, 2023

概括

专利分析显示,ROS1抑制剂中的独特的硫和元素与RET抑制剂不同. 这为向癌症治疗,特别是肺癌提供了新的见解.

科学领域:

在瘤学瘤学.
药用化学医学化学
知识产权分析知识产权分析

背景情况:

RET和ROS1正在成为新型癌症治疗的关键标.
了解这些目标的当前抑制剂的现状对于药物发现至关重要.
专利分析为治疗剂的结构特征提供了独特的视角.

研究的目的:

分析针对RET和ROS1.1的抑制剂的专利环境.
与RET和BRAF抑制剂相比,确定ROS1抑制剂的独特结构特征.
为未来发展向癌症治疗提供洞察力.

主要方法:

进行了全面的专利分析,重点关注ROS1和RET抑制剂.
对抗剂结构进行了比较,以确定独特的化学元素和特征.
研究了与每个目标相关的治疗应用和癌症类型.

主要成果:

与RET和BRAF抑制剂相比,ROS1抑制剂具有不同的结构元素.
该研究在大量ROS1抑制剂结构中确定了硫和元素.
RET抑制剂显示出治疗各种癌症的潜力,包括肺癌和甲状腺癌.
ROS1抑制剂主要用于肺癌治疗.

结论:

包括硫和在内的ROS1抑制剂的独特化学成分为药物设计提供了新的途径.
针对RET和ROS1的向疗法代表了瘤学药物发现的不断增长的领域.
这些发现为开发肺癌和其他固体瘤的创新治疗提供了新的视角.

关键词:

在RET的基础上,RET是RET.在ROS1上,它是ROS1的.癌症癌症癌症癌症癌症 patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent patent 专利景观专利景观针对性药物针对性药物

更多相关视频

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing

Published on: July 5, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

The Retinoblastoma Gene

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...